CAPS Medical
Not specified, Israel· Est.
Innovative plasma‑based catheter for selective, minimally invasive solid tumor ablation.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Innovative plasma‑based catheter for selective, minimally invasive solid tumor ablation.
Oncology
Technology Platform
Non‑thermal atmospheric plasma delivered via a disposable catheter for selective ablation of solid tumor tissue.
Opportunities
Large unmet need for selective, minimally invasive tumor ablation and potential to partner with surgical device manufacturers.
Risk Factors
Regulatory clearance uncertainty, need for robust clinical data, and competition from other ablative technologies.
Competitive Landscape
Few companies focus on non‑thermal plasma for oncology; CAPS Medical differentiates through selectivity and catheter‑based delivery versus thermal ablation or electroporation.